<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00013234</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 98-159</org_study_id>
    <nct_id>NCT00013234</nct_id>
  </id_info>
  <brief_title>Health Services Implications of a Teledermatology Consult System</brief_title>
  <official_title>Health Services Implications of a Teledermatology Consult System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We have previously shown (IIR 95-045) that teledermatology, using store and forward
      technology, can result in reliable and accurate diagnostic outcomes when compared to
      clinic-based dermatology consultations. This investigation builds on that fundamental
      diagnostic information by assessing the health services implications of a teledermatology
      consult system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      We have previously shown (IIR 95-045) that teledermatology, using store and forward
      technology, can result in reliable and accurate diagnostic outcomes when compared to
      clinic-based dermatology consultations. This investigation builds on that fundamental
      diagnostic information by assessing the health services implications of a teledermatology
      consult system.

      Objectives:

      To investigate health services outcomes related to teledermatology implementation. Outcomes
      of interest were time to diagnosis and treatment initiation, the proportion of patients that
      avoided the need for a clinic-based encounter, and an economic analysis.

      Methods:

      Patients referred from the primary care clinics to the dermatology consult service were
      randomized to either usual care or a teledermatology consultation. A usual care consultation
      consisted a conventional text-based electronic consult request. A teledermatology
      consultation included digital images and a standardized history, in addition to the
      electronic text-based consult. Consultant dermatologists, reviewing the consult requests for
      both modalities, decided when, and if, a referral required a clinic-based evaluation.

      Status:

      Final report has been prepared and is in the review process at this time.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <completion_date type="Actual">September 2003</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Teledermatology</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Teledermatology</intervention_name>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients referred to Dermatology Consult Service.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John D. Whited, MD MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center, Durham, NC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eugene Z. Oddone, MD MHSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center, Durham, NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Durham VA Medical Center, Durham, NC</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Whited JD, Datta S, Hall RP, Foy ME, Marbrey LE, Grambow SC, Dudley TK, Simel DL, Oddone EZ. An economic analysis of a store and forward teledermatology consult system. Telemed J E Health. 2003 Winter;9(4):351-60.</citation>
    <PMID>14980092</PMID>
  </results_reference>
  <results_reference>
    <citation>Whited JD. Teledermatology research review. Int J Dermatol. 2006 Mar;45(3):220-9. Review.</citation>
    <PMID>16533219</PMID>
  </results_reference>
  <results_reference>
    <citation>Whited JD, Hall RP, Foy ME, Marbrey LE, Grambow SC, Dudley TK, Datta SK, Simel DL, Oddone EZ. Patient and clinician satisfaction with a store-and-forward teledermatology consult system. Telemed J E Health. 2004 Winter;10(4):422-31.</citation>
    <PMID>15689645</PMID>
  </results_reference>
  <results_reference>
    <citation>Pak H, Triplett CA, Lindquist J, Grambow S, Whited JD. The effect of store-and-forward teledermatology on clinical course. International Journal of Dermatology. 2006 Mar 1; 45(3):220-9.</citation>
  </results_reference>
  <results_reference>
    <citation>Whited JD. The quality of telemedicine research. J Telemed Telecare. 2006;12(6):271-3.</citation>
    <PMID>17022832</PMID>
  </results_reference>
  <results_reference>
    <citation>Whited JD. Teledermatology. Current status and future directions. Am J Clin Dermatol. 2001;2(2):59-64. Review.</citation>
    <PMID>11705304</PMID>
  </results_reference>
  <results_reference>
    <citation>Whited JD, Hall RP, Foy ME, Marbrey LE, Grambow SC, Dudley TK, Datta S, Simel DL, Oddone EZ. Teledermatology's impact on time to intervention among referrals to a dermatology consult service. Telemed J E Health. 2002 Fall;8(3):313-21.</citation>
    <PMID>12419025</PMID>
  </results_reference>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2001</study_first_submitted>
  <study_first_submitted_qc>March 15, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2001</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

